Last 12 months
Inside the activity.
25 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 13 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 8 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2023 Filed Mar 1, 2023 00:27 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 7,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026879 · tm238076-4_4seq1.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,403 Underlying: Common Stock · 7,601 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2023, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2022 and February 28, 2023 and 50% of the LTIP Units will vest on February 28, 2024 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:29 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 7,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026881 · tm238076-5_4seq1.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,962 Underlying: Common Stock · 7,094 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2023, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2022 and February 28, 2023 and 50% of the LTIP Units will vest on February 28, 2024 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:24 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 4,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026878 · tm238076-3_4seq1.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,803 Underlying: Common Stock · 4,864 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2023, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2022 and February 28, 2023 and 50% of the LTIP Units will vest on February 28, 2024 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:21 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 4,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-026876 · tm238076-2_4seq1.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,203 Underlying: Common Stock · 4,732 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2023, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2022 and February 28, 2023 and 50% of the LTIP Units will vest on February 28, 2024 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 18:20 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 36,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025453 · tm237802-1_4seq1.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,667 Underlying: Common Stock · 36,563 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 23, 2026, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 23:22 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 27,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025454 · tm237802-2_4seq1.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,802 Underlying: Common Stock · 27,422 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 23, 2026, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 23:24 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 15,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025457 · tm237802-5_4seq1.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,471 Underlying: Common Stock · 15,996 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 23, 2026, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 23:24 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 15,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025456 · tm237802-4_4seq1.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,939 Underlying: Common Stock · 15,996 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 23, 2026, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 23:22 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 27,422 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-025455 · tm237802-3_4seq1.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,868 Underlying: Common Stock · 27,422 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 23, 2026, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 6, 2022. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| January 30, 2023 Filed Jan 31, 2023 16:05 UTC |
MOORE ROSCOE M JRDirector
|
Exercise / conversionLTIP Unit · Derivative | 7,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-008590 · tm235042-1_4.xml · derivative · entry 2 MOORE ROSCOE M JR · CIK 0001459411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,432 Underlying: Common Stock · 7,412 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F1 · derivative.exercise_price: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: Of the 7,412 LTIP Units redeemed for shares of the Issuer's common stock, (i) 2,185 LTIP Units were issued on May 29, 2019 and were fully vested on May 29, 2020, (ii) 3,116 LTIP Units were issued on September 2, 2020 and were fully vested on September 2, 2021 and (iii) 2,111 LTIP Units were issued on May 26, 2021 and were fully vested on May 26, 2022. F1 · derivative.expiration_date: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: Of the 7,412 LTIP Units redeemed for shares of the Issuer's common stock, (i) 2,185 LTIP Units were issued on May 29, 2019 and were fully vested on May 29, 2020, (ii) 3,116 LTIP Units were issued on September 2, 2020 and were fully vested on September 2, 2021 and (iii) 2,111 LTIP Units were issued on May 26, 2021 and were fully vested on May 26, 2022. Read SEC document |
| January 30, 2023 Filed Jan 31, 2023 16:05 UTC |
MOORE ROSCOE M JRDirector
|
Exercise / conversionCommon Stock | 7,412 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-008590 · tm235042-1_4.xml · nonDerivative · entry 1 MOORE ROSCOE M JR · CIK 0001459411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| January 10, 2023 Filed Jan 10, 2023 16:05 UTC |
MOORE ROSCOE M JRDirector
|
SaleCommon Stock | 5,000 | $9.79 | $48,956.50 |
DisclosureSEC source: 0001104659-23-002707 · tm233028-1_4seq1.xml · nonDerivative · entry 1 MOORE ROSCOE M JR · CIK 0001459411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 11, 2022 Filed May 24, 2022 20:16 UTC |
Cypher MatthewDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-064244 · tm2216653-3_4seq1.xml · derivative · entry 1 Cypher Matthew · CIK 0001670718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,789 Underlying: Common Stock · 5,321 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 11, 2023, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 11, 2022 Filed May 24, 2022 16:17 UTC |
MOORE ROSCOE M JRDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-064248 · tm2216653-5_4seq1.xml · derivative · entry 1 MOORE ROSCOE M JR · CIK 0001459411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,844 Underlying: Common Stock · 5,321 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 11, 2023, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 11, 2022 Filed May 24, 2022 20:17 UTC |
Wittman LoriDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-064251 · tm2216653-6_4seq1.xml · derivative · entry 1 Wittman Lori · CIK 0001615562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,844 Underlying: Common Stock · 5,321 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 11, 2023, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 11, 2022 Filed May 24, 2022 20:16 UTC |
Marston RonaldDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-064246 · tm2216653-4_4seq1.xml · derivative · entry 1 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,789 Underlying: Common Stock · 5,321 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 11, 2023, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 11, 2022 Filed May 24, 2022 20:16 UTC |
Crowley PaulaDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-064240 · tm2216653-2_4seq1.xml · derivative · entry 1 Crowley Paula · CIK 0001743595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,844 Underlying: Common Stock · 5,321 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 11, 2023, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 11, 2022 Filed May 24, 2022 20:15 UTC |
Cole HenryDirector
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,321 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-064235 · tm2216653-1_4seq1.xml · derivative · entry 1 Cole Henry · CIK 0001652393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,789 Underlying: Common Stock · 5,321 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on May 11, 2023, subject to the Reporting Person's continued service as a director on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 16:06 UTC |
MOORE ROSCOE M JRDirector
|
Exercise / conversionLTIP Unit · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-040111 · tm2210874-1_4seq1.xml · derivative · entry 2 MOORE ROSCOE M JR · CIK 0001459411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,523 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F1 · derivative.exercise_price: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: Of the 5,000 LTIP Units redeemed for shares of the Issuer's common stock, (i) 3,480 LTIP Units were issued on May 30, 2018 and were fully vested on May 30, 2019, and (ii) 1,520 LTIP Units were issued on May 29, 2019 and were fully vested on May 29, 2020. F1 · derivative.expiration_date: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: Of the 5,000 LTIP Units redeemed for shares of the Issuer's common stock, (i) 3,480 LTIP Units were issued on May 30, 2018 and were fully vested on May 30, 2019, and (ii) 1,520 LTIP Units were issued on May 29, 2019 and were fully vested on May 29, 2020. Read SEC document |
| March 29, 2022 Filed Mar 30, 2022 16:06 UTC |
MOORE ROSCOE M JRDirector
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-040111 · tm2210874-1_4seq1.xml · nonDerivative · entry 1 MOORE ROSCOE M JR · CIK 0001459411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 19:11 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 27,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-030737 · tm228477-5_4seq1.xml · derivative · entry 2 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580,104 Underlying: Common Stock · 27,698 shares Expires not disclosed F1 · security: The Issuer's Board of Directors determined on February 24, 2022 that 50% of the LTIP Units vested and became nonforfeitable on March 4, 2022 as a result of meeting certain market-based criteria as of March 4, 2022 and 50% of the LTIP Units will vest on March 4, 2023, pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 7, 2019. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 04, 2022 Filed Mar 5, 2022 00:08 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 19,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-030732 · tm228477d1_4seq1.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,380 Underlying: Common Stock · 19,268 shares Expires not disclosed F1 · security: The Issuer's Board of Directors determined on February 24, 2022 that 50% of the LTIP Units vested and became nonforfeitable on March 4, 2022 as a result of meeting certain market-based criteria as of March 4, 2022 and 50% of the LTIP Units will vest on March 4, 2023, pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 7, 2019. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 04, 2022 Filed Mar 5, 2022 00:09 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 13,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-030734 · tm228477-3_4seq1.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,943 Underlying: Common Stock · 13,246 shares Expires not disclosed F1 · security: The Issuer's Board of Directors determined on February 24, 2022 that 50% of the LTIP Units vested and became nonforfeitable on March 4, 2022 as a result of meeting certain market-based criteria as of March 4, 2022 and 50% of the LTIP Units will vest on March 4, 2023, pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 7, 2019. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 04, 2022 Filed Mar 5, 2022 00:10 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 25,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-030736 · tm228477-4_4seq1.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,446 Underlying: Common Stock · 25,290 shares Expires not disclosed F1 · security: The Issuer's Board of Directors determined on February 24, 2022 that 50% of the LTIP Units vested and became nonforfeitable on March 4, 2022 as a result of meeting certain market-based criteria as of March 4, 2022 and 50% of the LTIP Units will vest on March 4, 2023, pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 7, 2019. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 04, 2022 Filed Mar 5, 2022 00:09 UTC |
Barber Jamie AllenGeneral Counsel & Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 16,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-030733 · tm228477-2_4seq1.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,475 Underlying: Common Stock · 16,860 shares Expires not disclosed F1 · security: The Issuer's Board of Directors determined on February 24, 2022 that 50% of the LTIP Units vested and became nonforfeitable on March 4, 2022 as a result of meeting certain market-based criteria as of March 4, 2022 and 50% of the LTIP Units will vest on March 4, 2023, pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 7, 2019. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 21:48 UTC |
Cole HenryDirector
|
PurchaseCommon Stock | 1,287 | $15.54 | $19,999.47 |
DisclosureSEC source: 0001104659-22-031579 · tm228732-1_4seq1.xml · nonDerivative · entry 1 Cole Henry · CIK 0001652393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,732 Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 19:11 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
PurchaseCommon Stock | 2,000 | $15.55 | $31,100.00 |
DisclosureSEC source: 0001104659-22-030737 · tm228477-5_4seq1.xml · nonDerivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,490 Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 17:59 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 18,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-028822 · tm228091-5_4seq1.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 552,406 Underlying: Common Stock · 18,116 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2022, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and February 28, 2022 and 50% of the LTIP Units will vest on February 28, 2023 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:58 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 10,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-028818 · tm228091-3_4seq1.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,112 Underlying: Common Stock · 10,114 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2022, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and February 28, 2022 and 50% of the LTIP Units will vest on February 28, 2023 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:58 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 6,039 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-028819 · tm228091-4_4seq1.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,615 Underlying: Common Stock · 6,039 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2022, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and February 28, 2022 and 50% of the LTIP Units will vest on February 28, 2023 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:57 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 6,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-028816 · tm228091-1_4seq1.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,697 Underlying: Common Stock · 6,335 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2022, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and February 28, 2022 and 50% of the LTIP Units will vest on February 28, 2023 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 22:57 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 9,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-028817 · tm228091-2_4seq1.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,156 Underlying: Common Stock · 9,359 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined that on February 28, 2022, 50% of the LTIP Units will become vested and nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and February 28, 2022 and 50% of the LTIP Units will vest on February 28, 2023 pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.1 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 21:34 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 14,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027519 · tm227785-2_4seq1.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,290 Underlying: Common Stock · 14,858 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 24, 2025, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 24, 2022 Filed Feb 26, 2022 02:35 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 9,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027520 · tm227785-3_4seq1.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,998 Underlying: Common Stock · 9,905 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 24, 2025, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 24, 2022 Filed Feb 26, 2022 02:38 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 6,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027523 · tm227785-5_4seq1.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,576 Underlying: Common Stock · 6,191 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 24, 2025, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 24, 2022 Filed Feb 26, 2022 02:37 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 9,905 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027522 · tm227785-4_4seq1.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,797 Underlying: Common Stock · 9,905 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 24, 2025, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| February 24, 2022 Filed Feb 26, 2022 02:32 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 6,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-027518 · tm227785-1_4seq1.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,362 Underlying: Common Stock · 6,191 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on February 24, 2025, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 17:13 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
PurchaseCommon Stock | 1,000 | $15.01 | $15,010.00 |
DisclosureSEC source: 0001104659-21-108231 · tm2125636-1_4seq1.xml · nonDerivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,490 Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:32 UTC |
Cypher MatthewDirector
|
GrantLTIP Unit · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074212 · tm2117936-3_4seq1.xml · derivative · entry 1 Cypher Matthew · CIK 0001670718 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,468 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on May 26, 2022, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:36 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
GrantLTIP Unit (Right to Buy) · Derivative | 8,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074227 · tm2117936-10_4seq1.xml · derivative · entry 1 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 519,432 Underlying: Common Stock · 8,890 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on March 3, 2024, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 16:33 UTC |
MOORE ROSCOE M JRDirector
|
GrantLTIP Unit · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074216 · tm2117936-5_4seq1.xml · derivative · entry 1 MOORE ROSCOE M JR · CIK 0001459411 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,523 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: /s/ Roscoe Moore F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:34 UTC |
KIERNAN ROBERT JChief Financial Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074219 · tm2117936-7_4seq1.xml · derivative · entry 1 KIERNAN ROBERT J · CIK 0001229248 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,093 Underlying: Common Stock · 5,927 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on March 3, 2024, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:36 UTC |
Leon AlfonzoChief Investment Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 6,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074228 · tm2117936-11_4seq1.xml · derivative · entry 1 Leon Alfonzo · CIK 0001647511 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,892 Underlying: Common Stock · 6,519 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on March 3, 2024, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:35 UTC |
Barber Jamie AllenGeneral Counsel and Secretary
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074226 · tm2117936-9_4seq1.xml · derivative · entry 1 Barber Jamie Allen · CIK 0001705686 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,385 Underlying: Common Stock · 5,630 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on March 3, 2024, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:34 UTC |
Holley DanicaChief Operating Officer
|
GrantLTIP Unit (Right to Buy) · Derivative | 5,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074220 · tm2117936-8_4seq1.xml · derivative · entry 1 Holley Danica · CIK 0001657320 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,171 Underlying: Common Stock · 5,630 shares Expires not disclosed F1 · security: Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. All of the LTIP Units vest on March 3, 2024, subject to the Reporting Person's continued employment on such date. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 10.3 to the Issuer's Quarterly Report on Form 10-Q filed on May 7, 2021. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:33 UTC |
Wittman LoriDirector
|
GrantLTIP Unit · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074217 · tm2117936-6_4seq1.xml · derivative · entry 1 Wittman Lori · CIK 0001615562 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,523 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on May 26, 2022, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:32 UTC |
Marston RonaldDirector
|
GrantLTIP Unit · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074215 · tm2117936-4_4seq1.xml · derivative · entry 1 Marston Ronald · CIK 0001652392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,468 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on May 26, 2022, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:30 UTC |
Crowley PaulaDirector
|
GrantLTIP Unit · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074200 · tm2117936-2_4seq1.xml · derivative · entry 1 Crowley Paula · CIK 0001743595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,523 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on May 26, 2022, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 20:29 UTC |
Cole HenryDirector
|
GrantLTIP Unit · Derivative | 4,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-074199 · tm2117936-1_4seq1.xml · derivative · entry 1 Cole Henry · CIK 0001652393 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,468 Underlying: Common Stock · 4,222 shares Expires not disclosed F1 · security: Represents units of limited partnership ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. F2 · derivative.exercise_price: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F3 · shares: LTIP Units vest on May 26, 2022, subject to the Reporting Person's continued service as a director until such date. F2 · derivative.exercise_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. F2 · derivative.expiration_date: As described in the OP's partnership agreement, vested LTIP Units may be exchanged at any time after vesting for cash or, at the option of the Issuer, for shares of the Issuer's common stock on a one-for-one basis. LTIP Units have no expiration date. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 17:52 UTC |
Busch JeffreyDirector · Chairman, President and CEO
|
PurchaseCommon Stock | 1,000 | $13.81 | $13,810.00 |
DisclosureSEC source: 0001104659-21-033904 · tm219207d1_4seq1.xml · nonDerivative · entry 2 Busch Jeffrey · CIK 0001620772 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,490 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.